PharmaEssentia

About:

PharmaEssentia develops treatments for myeloproliferative neoplasms, hepatitis, and other diseases.

Website: https://us.pharmaessentia.com/

Twitter/X: pharmaessentia

Top Investors: Taiwania Capital Management Corporation

Description:

PharmaEssentia Corporation is a biopharmaceutical company that develops treatments for myeloproliferative neoplasms, and hepatitis. They deliver biologics for diseases in the areas of hematology and oncology, with products approved in a diversifying pipeline. Their services include biologics, oncology, rare disease, orphan drugs, orphan disease, drug development, pharmaceuticals, and hematology.